Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivos Therapeutics (VVOS) Goodwill & Intangibles (2019 - 2025)

Historic Goodwill & Intangibles for Vivos Therapeutics (VVOS) over the last 7 years, with Q3 2025 value amounting to $10.7 million.

  • Vivos Therapeutics' Goodwill & Intangibles rose 23081.22% to $10.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.7 million, marking a year-over-year increase of 23081.22%. This contributed to the annual value of $3.2 million for FY2024, which is 153.23% down from last year.
  • Vivos Therapeutics' Goodwill & Intangibles amounted to $10.7 million in Q3 2025, which was up 23081.22% from $10.7 million recorded in Q2 2025.
  • Vivos Therapeutics' Goodwill & Intangibles' 5-year high stood at $10.7 million during Q2 2025, with a 5-year trough of $3.0 million in Q1 2021.
  • Over the past 5 years, Vivos Therapeutics' median Goodwill & Intangibles value was $3.2 million (recorded in 2024), while the average stood at $4.1 million.
  • Per our database at Business Quant, Vivos Therapeutics' Goodwill & Intangibles plummeted by 4098.33% in 2022 and then surged by 23122.3% in 2025.
  • Vivos Therapeutics' Goodwill & Intangibles (Quarter) stood at $3.2 million in 2021, then dropped by 1.22% to $3.1 million in 2022, then grew by 3.75% to $3.3 million in 2023, then dropped by 1.53% to $3.2 million in 2024, then skyrocketed by 232.15% to $10.7 million in 2025.
  • Its last three reported values are $10.7 million in Q3 2025, $10.7 million for Q2 2025, and $3.2 million during Q1 2025.